Matthew Davids, MD, MMSc
Matthew Davids, MD, MMSc, got his A.B. from Harvard College in chemistry and his M.D. from Yale University School of Medicine. In New York City, he worked as an intern, resident, and assistant chief resident in internal medicine at New York-Presbyterian Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center.
Lisaftoclax (APG-2575): In CLL/SLL Treatment: Safety and Efficacy as Monotherapy or Combined with Acalabrutinib or Rituximab Matthew Davids MD - Synopsis below extracted from the video transcript.
Read More
Acalabrutinib (AVO): A Promising New Triplet Treatment Option for High-Risk CLL Patients Phase 2 Study Results Matthew Davids MD - Synopsis below extracted from the video transcript.
Read More
